VisionWave Acquires QuantumSpeed for Approximately $99.6 Million
VisionWave Holdings announced the acquisition of QuantumSpeed, an early-stage, pre-commercial computational acceleration engine that is intended to explore new approaches to execute complex computations under extreme time constraints. QuantumSpeed is not yet a commercial product. The technology is currently in a proof-of-concept and system architecture phase, where core mathematical, algorithmic, and architectural principles have been defined and validated at a prototype level. VisionWave is initiating a focused development program to advance the engine toward production-grade deployment. There can be no assurance that the technology will advance beyond the current proof-of-concept phase, achieve targeted performance metrics, or ever result in a commercial product. Development involves substantial technical, financial, and regulatory risks. An independent third-party valuation by BDO Consulting Group assessed the QuantumSpeed intellectual property at approximately $99.6M as of December 31, 2025, based on certain assumptions regarding future development success, market adoption, and discount rates. This valuation is not a guarantee of realizable value and is subject to significant risks, including potential impairment if development milestones are not met. The Company's Board was provided also with a fairness opinion by BDO Consulting Group for the structure and the value of the transaction. At closing, VisionWave acquired 100% of the QuantumSpeed intellectual property assets, which will be transferred into a newly formed, wholly owned subsidiary. As previously disclosed, transaction consideration includes: 3,000,000 shares of VisionWave common stock issued at closing; A $10M promissory note; 7,000,000 additional shares subject to shareholder approval under applicable Nasdaq rules. A structured equity pledge mechanism has been implemented to align incentives and protect execution, with defined remedies if shareholder approval is not obtained within the prescribed timeframe.
Analyst Views on VWAV
About VWAV
About the author






